Worth reading
61In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
4510000
Japanese yen (total issue price)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance through third-party allotment of Series 22 and Series 23 Stock Acquisition Rights with clauses for revision of the exercise price
Who receives how much
Series 22: 89,000 rights (100 common shares per right; potential shares: 8,900,000), Series 23: 5,000 rights (100 common shares per right; potential shares: 500,000)
Macquarie Bank LimitedEquivalent to 8,900,000 shares for Series 22 and 500,000 shares for Series 23
The lower thin line represents the existing number of shares to which these shares will be added.
Series 22: ¥50 per right; Series 23: ¥12 per right
Total issue value
¥4,510,000 (Series 22: ¥4,450,000; Series 23: ¥60,000)
Amount of funds to be raised
Series 22: ¥2,427,200,000 (estimated net proceeds after deducting expenses); Series 23: ¥300,000,000 (total amount including the issue price; estimated net proceeds: Not disclosed)
Estimated issuance expenses
¥47,000,000 (expenses associated with the issuance of the Series 22, Series 23 and Series 24 Stock Acquisition Rights)
Terms of the stock acquisition rights
Exercise price
Series 22: initially ¥278, adjusted to 94% of the closing price, with a floor of ¥148; Series 23: initially ¥600, adjusted to 94% of the closing price if the Company exercises its adjustment option, with a floor of ¥148
Exercise period
8 May 2026 to 8 May 2028
Number of Stock Acquisition Rights
Total issued: 89,000 Series 22 rights and 5,000 Series 23 rights; unexercised balance: Not disclosed
Payment date
7 May 2026
Most recent equity financing
Issuance of new shares and Series 22, Series 23 and Series 24 Stock Acquisition Rights through third-party allotment resolved on 21 April 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance through third-party allotment of Series 22 and Series 23 Stock Acquisition Rights with clauses for revision of the exercise price |
| Number of shares to be issued or disposed of | Series 22: 89,000 rights (100 common shares per right; potential shares: 8,900,000), Series 23: 5,000 rights (100 common shares per right; potential shares: 500,000) |
| Issue price and disposal price | Series 22: ¥50 per right; Series 23: ¥12 per right |
| Total issue value | ¥4,510,000 (Series 22: ¥4,450,000; Series 23: ¥60,000) |
| Amount of funds to be raised | Series 22: ¥2,427,200,000 (estimated net proceeds after deducting expenses); Series 23: ¥300,000,000 (total amount including the issue price; estimated net proceeds: Not disclosed) |
| Estimated issuance expenses | ¥47,000,000 (expenses associated with the issuance of the Series 22, Series 23 and Series 24 Stock Acquisition Rights) |
| Payment date | 7 May 2026 |
| Intended allottee | Name Macquarie Bank Limited / Number of Shares Equivalent to 8,900,000 shares for Series 22 and 500,000 shares for Series 23 |
| Exercise price | Series 22: initially ¥278, adjusted to 94% of the closing price, with a floor of ¥148; Series 23: initially ¥600, adjusted to 94% of the closing price if the Company exercises its adjustment option, with a floor of ¥148 |
| Exercise period | 8 May 2026 to 8 May 2028 |
| Number of Stock Acquisition Rights | Total issued: 89,000 Series 22 rights and 5,000 Series 23 rights; unexercised balance: Not disclosed |
| Most recent equity financing | Issuance of new shares and Series 22, Series 23 and Series 24 Stock Acquisition Rights through third-party allotment resolved on 21 April 2026 |
Items this document does not state (16)
Specific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price by the prospective allottee has been completed for the issuance of Stock Acquisition Rights resolved by the Board of Directors on 21 April 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.